Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
Recursion official investor newsroom · 行业原文收录 · 来源发布:Thu Oct 15 2026 12:31:00 GMT+0000 (Coordinated Universal Time) · 本站收录:Thu Oct 15 2026 13:07:58 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock October 15, 2026 at 8:30 AM EDT PDF Version Salt Lake City, UT , Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development decoding biology to radically improve lives, today announced
以上为带出处的原文节选,完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。